PALISADE BIO, INC. — Director's Dealing 2010

Nov 23, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2010-07-12

Reporting Person: OGILVIE SCOTT VARDE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-15	Common Stock	A	15000	—	Acquired	15000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-07-12	Common Stock Purchase Option (Right to Buy)	$2.51	A	20000	Acquired	2017-07-12	Common (20000)	Direct
2010-07-12	Common Stock Option (Right to Buy)	$2.51	A	15000	Acquired	2017-07-12	Common (15000)	Direct

Footnotes

F1: Represents restricted stock grant under the Issuer's amended outside director compensation plan. The shares are 100% vested
on the grant date.

F2: Represents compensatory Annual Grant for director services. The option vests quarterly over the grant year.

F3: Represents compensatory Committee Grant for service on the: (i) Audit; (ii) Compensation, and (iii) Nomination committees of
the board (5,000 each committee). The option vests quarterly over the grant year.